Correlation of angiotensin converting enzyme activity and the genotypes of the I/D polymorphism in the ACE gene with preterm birth and birth weight

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 141, Issue 1, 2008, Pages 27-30

  Uma, Ramalingam ^a   Forsyth, J Stewart ^a   Struthers, Allan D ^a   Fraser, Callum G ^b   Godfrey, Valerie ^a   Murphy, Deirdre J ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

Author keywords

ACE genotype; Birth weight; Preterm birth; Serum angiotensin converting enzyme

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 54849414173     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.07.006     Document Type: Article

References (23)

1. Varner M.W., and Esplin M.S. Current understanding of genetic factors in preterm birth. BJOG 112 Suppl. 1 (2005) 28-31
2. Macones G.A., Parry S., Elkousy M., Clothier B., Ural S.H., and Strauss III J.F. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 190 (2004) 1504-1508 [discussion 3A]
3. Morgan T., Craven C., and Ward K. Human spiral artery renin-angiotensin system. Hypertension 32 (1998) 683-687
4. Kim Y.M., Bujold E., Chaiworapongsa T., et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 189 (2003) 1063-1069
5. Kim Y.M., Chaiworapongsa T., Gomez R., et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 187 (2002) 1137-1142
6. Walther T., Faber R., Maul B., Schultheiss H.P., Siems W.E., and Stepan H. Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE). Prenat Diagn 22 (2002) 111-113
7. Buchholz T., Lohse P., Rogenhofer N., Kosian E., Pihusch R., and Thaler C.J. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 18 (2003) 2473-2477
8. Kobashi G., Hata A., Shido K., et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients. Semin Thromb Hemost 31 (2005) 346-350
9. Mello G., Parretti E., Gensini F., et al. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 41 (2003) 932-937
10. Gardosi J., Chang A., Kalyan B., Sahota D., and Symonds E.M. Customised antenatal growth charts. Lancet 339 (1992) 283-287
11. Shanmugam V., Sell K.W., and Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl 3 (1993) 120-121
12. Uma R., Forsyth J.S., Struthers A.D., Fraser C.G., and Murphy D.J. The influence of mode of delivery and ACE genotype on serum angiotensin converting enzyme (ACE) activity in the mother and infant at term. Eur J Obstet Gynecol Reprod Biol (2006)
13. Serrano N.C., Diaz L.A., Paez M.C., et al. Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med 3 (2006) e520
14. Valdez L.L., Quintero A., Garcia E., et al. Thrombophilic polymorphisms in preterm delivery. Blood Cells Mol Dis 33 (2004) 51-56
15. Hindmarsh P.C., Rodeck C.H., and Humphries S.E. Polymorphisms in the angiotensin converting enzyme gene and growth in the first year of life. Ann Hum Genet 71 (2007) 176-184
16. Forsyth J.S., Reilly J., Fraser C.G., and Struthers A.D. Angiotensin converting enzyme activity in infancy is related to birth weight. Arch Dis Child Fetal Neonatal Ed 89 (2004) F442-F444
17. Morgan T., Craven C., Lalouel J.M., and Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 180 (1999) 95-102
18. Nakamura S., Nakamura I., Ma L., Vaughan D.E., and Fogo A.B. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int 58 (2000) 251-259
19. van Leeuwen R.T., Kol A., Andreotti F., Kluft C., Maseri A., and Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90 (1994) 362-368
20. Ridker P.M., Gaboury C.L., Conlin P.R., Seely E.W., Williams G.H., and Vaughan D.E. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87 (1993) 1969-1973
21. Schmieder R.E., Hilgers K.F., Schlaich M.P., and Schmidt B.M. Renin-angiotensin system and cardiovascular risk. Lancet 369 (2007) 1208-1219
22. Dilley A., Austin H., El-Jamil M., et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 183 (2000) 1271-1277
23. Nishimura H., Tsuji H., Masuda H., et al. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 77 (1997) 1189-1195